Understanding the neural mechanisms of lisdexamfetamine dimesylate (LDX) pharmacotherapy in Binge Eating Disorder (BED): a study protocol

BACKGROUND: The efficacy and safety of Lisdexamfetamine dimesylate (LDX) in the treatment of moderate to severe binge eating disorder (BED) has been demonstrated in multiple randomised clinical trials. Despite this, little is known about how LDX acts to improve binge eating symptoms. This study aims...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Eat Disord
Main Authors: Griffiths, Kristi R., Yang, Jenny, Touyz, Stephen W., Hay, Phillipa J., Clarke, Simon D., Korgaonkar, Mayuresh S., Gomes, Linette, Anderson, Gail, Foster, Sheryl, Kohn, Michael R.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6621979/
https://ncbi.nlm.nih.gov/pubmed/31333843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40337-019-0253-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados